Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 20, 2024
Memory B cell-guided extended interval dosing of ocrelizumab in multiple sclerosisDelania Meng, Rosaria Sacco, Giulio Disanto, et al.
BMC Neurology|August 7, 2013
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trialClaudio Gobbi, Dominik S Meier, François Cotton, et al.
BMC Neurology|March 1, 2014
Treatment satisfaction, adherence and behavioral assessment in patients de-escalating from natalizumab to interferon βChiara Zecca, Gianna C Riccitelli, Pasquale Calabrese, et al.
Annals of Clinical and Translational Neurology|September 25, 2023
Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathyGiulio Disanto, Michele Villa, Aleksandra Maleska Maceski, et al.
Multiple Sclerosis and Related Disorders|November 7, 2024
De-escalation from anti-CD20 to cladribine tablets in multiple sclerosis: A pilot studyRosaria Sacco, Giulio Disanto, Emanuele Pravatà, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2017
Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosisEmanuele Pravatà, Maria A Rocca, Paola Valsasina, et al.
Epilepsy & Behavior : E&B|August 4, 2019
Serum neurofilament light chain as a prognostic marker in postanoxic encephalopathyGiulio Disanto, Chiara Prosperetti, Claudio Gobbi, et al.
Pageof 17